update of rosacea · • azelaic acid gel 15%/ 20% lotion/ cream/ foam • benzoyl peroxide/...

19
15/09/2016 1 Dr Samantha Eisman Dermatologist Sinclair Dermatology MBChB MRCP(UK) FCDerm(SA) FACD Update of Rosacea Sinclair Dermatology Professor Rod Sinclair Acknowledgment photographs Chronic skin disorder of vascular origin Skin of central face (convexities) Woman Skin type I and II Prevalence 0,5%22% 1,78 Million in Australia Low self esteem Rosaceadefinition

Upload: others

Post on 23-Oct-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

  • 15/09/2016

    1

    • Dr Samantha Eisman

    • Dermatologist Sinclair Dermatology• MBChB MRCP(UK) FCDerm(SA) FACD

    Update of Rosacea

    • Sinclair Dermatology • Professor Rod Sinclair

    Acknowledgment ‐ photographs

    • Chronic skin disorder of vascular origin• Skin of central face (convexities)• Woman• Skin type I and II

    • Prevalence 0,5%‐22%• 1,78 Million in Australia• Low self esteem

    Rosacea‐ definition

  • 15/09/2016

    2

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

    Clinical Signs

    Increased vascularity

    InflammationAround vessels

    ROSACEA Disrupts barrier/ papules/ pustules

    Flush/ erythema/Dilated capillaries

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic

    ROSACEA

  • 15/09/2016

    3

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    ROSACEA

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    infection

    ROSACEA

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    infection

    ROSACEA

    Dysregulation innate immunity‐increase toll‐like R‐2‐increase cathelicidin‐Increase kallikrein 5‐increase MMP

  • 15/09/2016

    4

    • Primary Features‐ one or more in central face

    • Flushing• Non transient erythema• Papules and pustules (no comedones)• Telangiectasia

    Diagnostic Criteria

    • Secondary Features‐ one/more may be present

    • Burning/ stinging/dryness/scaling• Red plaques/phymatous changes/oedema• Eyes signs• Peripheral location

    Diagnostic Criteria

    • 1. Erythematotelangiectatic (12%)

    • 2. Papulopustular (69%)

    • 3. Phymatous (3,7%)

    • 4. Ocular (6‐50%)

    • 5. Variants 

    Subtypes

  • 15/09/2016

    5

    • Flushing• Persistent central facial erythema (spare periocular)• Burning and stinging• Irritation from topical substances• Minimal inflammatory lesions/scale

    1. Erythematotelangiectatic (ETT)

    • Redness central face• Telangiectasia• Spare periocular skin• Papules and pustules (transient)• Oedema may be present• Flushing (mild)

    2. Papulopustular

    • Sebaceous hyperplasia• Skin thickens• Irregular surfaces and nodularities/ prominent pores• Nose/chin/forehead/eyelids

    3. Phymatous

    rhynophyma

    gnatophymametophyma

  • 15/09/2016

    6

    • May precede skin signs• 50‐70% patients• Unilateral or asymmetrical • Decrease tear secretion and Meibomian gland dysfunction• 20% present eyes first/ 50% present skin first

    4. Ocular/ Eye involvement

    injection

    • More than 1• Burning/ blurred vision/ stinging/ itching/ light sensitivity/ 

    FB/watery/ bloodshot/ dryness/telangiectasia conjunctiva or lid/ lid and periocular erythema

    • Conjunctivitis• Blepharitis• Stye (chalazion)• Meibomian gland inflammation• Rosacea keratitis (5%)‐ corneal involvement

    4. Ocular/ Eye involvement

    • Granulomatous• Chronic Lymphoedema• Steroid induced• Rosacea fulminans

    5. Variants

    lymphoedema

    Steroid induced

    Rosacea fulminans

    granulomatous

  • 15/09/2016

    7

    • Acne• Perioral dermatitis• Keratosis Pilaris• Seborrhoeic dermatitis• Photodermatitis (seasonal/ extrafacial)• Contact dermatitis (scale/ eczematous/ site application)• Systemic Lupus erythematosis (malar/ photosensitivity)• DLE (follicular plug/ scale /pigmentary changes/ scar)• Sarcoidosis (no skin surface changes/ smooth)• Tinea facei

    Differential diagnosis

    • Comedones• Not limited face• Younger age onset• No telangiectasia or flushing

    • Both‐ papules/ pustules/ erythema

    Acne

  • 15/09/2016

    8

    • monomorphic papules• Around orifices• Smaller lesions• No telangiectasia/ flush/blush

    Peri‐oral dermatitis

    • Fixed erythema• Small follicular keratotic plugs• Arms and thighs• Younger patient

    Keratosis pilaris

    • Eczematous• Greasy scale in scalp and brow/ earparanasal/nasolabial/ extrafacial

    • Often co‐ exist

    • Both‐ erythema/ blepharitis

    Seborrhoeic dermatitis

  • 15/09/2016

    9

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment of Rosacea

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

    • Heat (exercise/ bath/ food/ clothes/ heating home)• Exertion• Emotions (anger/ embarrassment/ stress)• Weather (wind/ heat)• Food (pepper/ coffee/ tea/ citrus/ tomato/choc)• Topical products (cosmetics/ toners/anti‐wrinkle/acne/fragrance)• Drugs (vasodilators/ steroids/ tamoxifen/ erectile dysfunction/ 

    metformin/ nicotinic acid)

    Treatment‐ avoid trigger

  • 15/09/2016

    10

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

    • Soap Free washes

    • Simple emollients (apply after medicated products)

    • Sun protection (UVA and UVB)‐ at least SPF 30

    • Cosmetics

    Treatment‐ Skin care

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

  • 15/09/2016

    11

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

    Treatment of inflammatory component‐Papulopustular

    (papules/ pustules/ phymatous)

    • Topical• Antibiotics• Anti‐inflammatory

    • Systemic (extensive or non‐ responsive)• Antibiotics (off‐label use)• Isotretinoin (off‐label)• ivermectin

    • Laser/ Surgery

    • Metronidazole 0,5%/ 1%/0,75% / cream/gel/ointment/ lotion

    • Erythromycin gel

    • Clindamycin lotion 

    Topical antibiotics

  • 15/09/2016

    12

    • Azelaic acid gel 15%/ 20% lotion/ cream/ foam

    • Benzoyl peroxide/ +/‐ clindamycin or erythromycin

    • Retinoids (adapalene cream/gel and tretinoin cream/gel)

    • Calcineurin inhibitors (pimecrolimus and tacrolimus)

    • Sulphacetamide 10%/ sulphur 5% lotion/ cream

    • Ivermectin 1% cream / permethrin 5% cream

    Topical anti‐inflammatory

    • First line antibiotics• Doxycycline/ minocycline 50‐100mg daily

    • Second line antibiotics• Erythromycin 250mg‐500mg BD/QDS or 400mg BD• Clarithromycin 250mg‐500mg BD/QDS• Azithromycin 250mg 3weekly/ 1000mg 45 days then 500mg 45 

    days)• Amoxycillin• Bactrim• Metronidazole 200mg BD 6 weeks

    • Isotretinoin‐ low dose/ longterm• Ivermectin

    Systemic treatment

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

  • 15/09/2016

    13

    Treatment of Vascular Component‐Erythematotelangiectatic

    Redness/ telangiectasia/ flushing

    Topical vasoconstrictorsSystemicLaser Surgery  

    • Brimonidine 0,5% gel

    • Oxymetazoline 0.05% solution (nasal)

    • ‐

    Topical vasoconstrictors

    • B blockers• Clonidine• Aspirin • Naloxone• Ondansetron• SSRIs• Contraceptive pill• Amitriptyline

    • Botox 

    Systemic treatment for flushing

  • 15/09/2016

    14

    • Telangiectasia/ persisting erythema AND symptoms

    • Short wavelength Lasers (superficial vessels and persistent erythema)• Pulsed dye laser/ long pulsed dye laser• Long‐pulse KTP laser

    • IPL

    • Diathermy

    Laser/Surgery

    • Artificial tears• Eyelid hygiene• Warm compress and massage• Cyclosporine 2% drops/ 0,05% emulsion• Metronidazole eye drops (compounded)• !0% sulphacetamide eye drops • Azithromycin 1,5% drops• Azithromycin and other oral antibiotics

    • Ophthalmology review

    Treatment Eyes

    • High quality evidence• Topical azelaic acid/ ivermectin/ brimonidine• Doxy/ isotretinoin

    • Moderate quality evidence• Topical metronidazole• Oral tetracyclines

    • Low quality evidence• Low dose minocycline (45mg)• IPL AND laser• Cyclosporine ophthalmic emulsion

    Cochrane review 2015

  • 15/09/2016

    15

    • Topical serine protease inhibitors/? Cathelicidin blockers

    • Topical mast cell stabilisers (cromolyn sodium)

    • Nitric oxide inhibitors ( vasoconstrictors)

    Future Treatments

    • 45 year old woman• C/O 1 year flushing when eats spicy food or drinks red wine• Metronidazole burns• Azelaic acid too drying• Doxy and minocycline 8 weeks each• Uses thick make up to conceal• Many cosmetics sting/ burn

    Case 1 

    • Lifestyle modification• Skin care ( emollient/ sunscreen/ soap free wash/ avoid 

    toners/ mineral make up)

    • Combination• Topical anti‐inflammatory/antibiotic

    • pimecrolimus/ azelaic acid/ metronidazole• Topical  vasoconstrictor

    • Brimonidine® gel• Oral antibiotic‐ doxy 100mg daily 3/12 (if inflammatory)• Laser/ light ( decrease recurrence after ab)

    ETT rosacea

  • 15/09/2016

    16

    • Reduces moderate to severe erythema• 5 DBPCT confirm effectiveness• TGA 2014

    • Onset action 30 min• Lasts 12 hr• SE‐mild and transient worsening erythema/flushing• Expensive

    Brimonidine® gel

    • Lifestyle modification• Skin care ( emollient/ sunscreen/ soap free wash/ avoid 

    toners/ mineral make up)

    • Combination• Topical anti‐inflammatory/antibiotic

    • pimecrolimus/ azelaic acid/ metronidazole• Topical  vasoconstrictor

    • Brimonidine® gel• Oral antibiotic‐ doxy 100mg daily 3/12 (if inflammatory)• Laser/ light ( decrease recurrence after ab)

    ETT rosacea

    Pulsed dye laser

  • 15/09/2016

    17

    • 68 year old man• Red face• No ETOH• Good skin care• Tried many topicals• Tried Doxy• Tried Laser 

    Case 2

    • Environmental/ trigger factors• Skin Care• Combination

    • Topical anti‐inflammatory‐ azelaic acid/ pimecrolimus• Topical antibiotic‐ metronidazole• Topical Ivermectin

    • Oral antibiotics

    • Isotretinoin (referral)

    • Maintenance• Taper antibiotics• Topicals 6‐9 months

    Papulopustular rosacea

  • 15/09/2016

    18

    • Anti‐parasite and anti‐inflammatory• FDA 2014/ TGA 2015• Inflammatory lesions (mod‐severe PPR rosacea)• Once daily• Superior to vehicle in two DBRCT• 38‐40% clear after 12 weeks (cf 12‐19% vehicle)• Burning 

  • 15/09/2016

    19

    • As for papulopustular rosacea

    • Isotretinoin ( before and or after laser)

    • Ablative lasers‐ CO2 and erbium;YAG

    • Surgery/ Electrosurgery/ dermabrasion / cryosurgery

    • Psyche

    Rhynophyma

    • Non contagious inflammation of skin of face

    • Cause unknown but many new theories (therapeutic targets)

    • No cure but options for control

    • Avoid triggers and good skin care

    • Variety of topicals/ medications and laser‐ subtype

    • Non responders/ eye disease – referral

    • Online support groups 

    Take home